Loading...
Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management
Aromatase inhibitors are widely used as adjuvant therapy in postmenopausal women with hormone receptor-positive breast cancer. While the agents are associated with slightly improved survival outcomes when compared to tamoxifen alone, bone and musculoskeletal side effects are substantial and often le...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2011
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3219175/ https://ncbi.nlm.nih.gov/pubmed/21457526 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr2818 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|